PharVision Advisers »

IDEXX Laboratories shares owned by PharVision Advisers

Quarter-by-quarter ownership of IDEXX Laboratories (IDXX) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in IDEXX Laboratories

Tip: Access up to 7 years of quarterly data

All positions including IDEXX Laboratories held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in IDEXX Laboratories by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $313k 463 676.53

More positions owned by PharVision Advisers

ExlService Holdings (EXLS)
Delek Us Holdings (DK)
Fiverr Intl Ord Shs (FVRR)
Asana Cl A (ASAN)
Broadcom (AVGO)
Itron (ITRI)
Brinker International (EAT)
Herbalife Com Shs (HLF)
NVIDIA Corporation (NVDA)
Evolv Technologies Hldngs In Com Cl A (EVLV)
Las Vegas Sands (LVS)
Vici Pptys (VICI)
Century Aluminum Company (CENX)
Agilent Technologies Inc C ommon (A)
Vail Resorts (MTN)

View all positions for PharVision Advisers

Top funds holding IDEXX Laboratories

Vanguard Group
BlackRock
Elyxium Wealth
State Street Corporation
J. Stern & Co
Geode Capital Management
Bamco
Fundsmith
Bank of New York Mellon
Invesco
William Blair $ Company
Principal Financial Group
Polen Capital Management
Northern Trust
Jpmorgan Chase & Co

View all funds holding IDEXX Laboratories